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CASE REPORT

ANAESTHETIC MANAGEMENT OF NESIDIOBLASTOSIS IN TWO
INFANTS
Muhammad Saad Yousuf, Mohsin Nazir Butt, Fauzia Anis Khan
Department of Anaesthesiology, Aga Khan University Hospital Karachi-Pakistan

Nesidioblastosis is the most common cause of non-transient, recurrent and persistent
hypoglycaemia in neonates and infants. It is a disorder of diffuse proliferation of beta cells of the
pancreas leading to hyperinsulinemia and hypoglycaemia. The main aim is to prevent the severe
episodes of hypoglycaemia which can cause damage to the brain and/or mental retardation. In this
case report we present two cases of nesidioblastosis and their perioperative anaesthetic course for
near-total pancreatectomy. First case was a 7 months old female who had repeated episodes of
convulsions since birth. Second case was a 4-month-old female child who again presented with
seizures. The challenges faced in the perioperative period were the management of perioperative
blood glucose levels and haemodynamic stability.
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INTRODUCTION
Nesidioblastosis is a rare cause of hypoglycaemia in
infancy due to unregulated over secretion of insulin.1
Treatment varies from medical management to partial
or subtotal pancreatectomy.2 Early diagnosis and
prompt treatment are essential to prevent
developmental delay and neurological damage.
We present two cases of nesidioblastosis in
infants with symptoms of severe hypoglycaemia
associated with seizures, requiring surgical treatment.

CASE REPORT
Case 1: A seven months old female child weighing
10.7 kg was admitted with repeated episodes of
convulsions since day two of life associated with
blood glucose level of 25 mg/dl. Physical
examination and insulin level were normal.
Ultrasonography of abdomen, renal and liver function
tests were within normal limits. The infant was
managed with intravenous (IV) half strength dextrose
saline, two hourly feeds, levetiracetam 100 mg BID
and somatostatin 50 mcg subcutaneously (S/C) 6
hourly. She was scheduled electively for a near-total
pancreatectomy.
Intravenous infusion of half strength dextrose
and all drugs was continued. Blood sugar was checked
every 30 minutes using ACCU-Check blood glucose
meter and remained between 80 and 150 mg/dl.
Intraoperative monitoring included pulse oximetry,
electrocardiogram, non-invasive blood pressure, endtidal carbon dioxide, temperature(oral), minimum
alveolar concentration of inhalational agents, blood
sugar and urine output. Bladder was catheterized and the
urine output was measured.
Induction of anaesthesia was done with IV
morphine 0.1 mg/kg, Propofol 2 mg/kg and atracurium
0.5 mg/kg. Trachea was intubated with size 4.0 mm

uncuffed endotracheal tubes. Anaesthesia was
maintained with a mixture of oxygen: air (50:50), and
isoflurane 1.0–1.3%. A central venous cannula was then
inserted in the right femoral vein.
Half strength dextrose saline (50 ml/hr) was
infused throughout. Blood sugar was estimated every 30
minutes, which was between 64 and 380 mg/dl (Figure1). Surgery lasted two hours. Intraoperative
haemodynamic parameters were stable and procedure
was uneventful. Estimated blood loss was 10 ml.
Atropine (0.02 mg/kg) and neostigmine (0.05 mg/kg)
was administered, trachea was extubated and patient
shifted to neonatal intensive care unit (NICU).
Postoperative analgesia was provided by morphine
infusion 0.2 mg/hr for next two days.
In the NICU, there were multiple episodes of
hypoglycaemia (as low as 42 mg/dl) but no fits. Twelve
percent dextrose at the rate of 8 mg/kg/min was started
along with somatostatin 20 mcg subcutaneously every 6
hours and levetiracetam 100mg BID. After 48 hours,
liquid diet was started 10 ml every 2 hourly and the
blood sugar levels were stabilized around (50–260
mg/dl) on oral feeds and half strength dextrose saline.
Patient was discharged on the 16th postoperative day.
Nesidioblastosis was reported in the histopathological
specimen.
Case 2: A four month old female infant weighing 5.7 kg
was admitted with complaint of decreased oral intake,
repeated episodes of convulsions and blood glucose
level was 24 mg/dl. A genetic test for hyperinsulinemia
revealed
an
autosomal
recessive
congenital
hyperinsulinism. Management with intravenous
dextrose 12% (20 ml/hr), somatostatin 40 mcg
subcutaneously TID, diazoxide 25 ml per oral BID and
levetiracetam 50 mg BID was started. A CT scan and
ultrasound of the whole abdomen were normal. She was
scheduled electively for a near-total pancreatectomy.

http://www.jamc.ayubmed.edu.pk

689

J Ayub Med Coll Abbottabad 2017;29(4)

Intravenous infusion of 12% dextrose along with all the
other drugs was continued. Blood sugar was checked
two hourly by ACCU-Check blood glucose meter and
was remained between 100 and 250 mg/dl. Anaesthesia
was induced with sevoflurane and followed by IV
morphine (0.1 mg/kg) and atracurium 0.5 mg/kg.
Intraoperative monitoring was same as in previous
patient. Trachea was intubated with size 3.0 mm
uncuffed endotracheal tube. Anaesthesia was
maintained with oxygen and air (50:50), isoflurane (1.0–
1.4%) and atracurium boluses. A central venous line
was inserted in the right femoral vein. Dextrose solution
(10% of 20 ml/hr) and Ringer’s lactate was
administered at a rate of 10 ml/kg/hr. Blood sugar was
estimated every 30 min, and ranged between 108 and
280 mg/dl. Haemodynamic parameters were stable and
procedure was uneventful. Estimated blood loss was 10
ml. Atropine (0.02 mg/kg) and neostigmine (0.05
mg/kg) was given to reverse the residual neuromuscular
blockade. Atropine (0.02 mg/kg) and neostigmine (0.05
mg/kg) was administered, trachea was extubated and
patient shifted to NICU. Postoperative analgesia was
provided by morphine infusion 0.1 mg/hr for next two
days.
She was initially hyperglycaemic, but later
developed two episodes of hypoglycaemia (43 mg/dl
and 50 mg/dl), for which 20 ml of 15% dextrose
solution was infused slowly. Somatostatin was restarted
at 15 mcg/kg/day. Her blood sugar levels were
stabilized between 90 and 150 mg/dl. After one day, the
patient’s condition remained stable. Mother’s feed of 30
ml was then started every 2 hours with IV infusion of
half strength dextrose saline at the rate of 5 ml/hr. The
patient was discharged on the ninth post-operative day.
Nesidioblastosis was reported in the histopathological
resected specimen. Perioperative blood sugar
management of both cases is shown in figure-1.

Figure-1: Intraoperative blood sugar level in both
patients
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DISCUSSION
Nesidioblastosis is due to mutation in the genes
regulating the function of the KATP channel located
on the beta (cell membrane.3 The annual
incidence of the sporadic form in infants is 1 in
50,000 births.4 Glucose requirement of infants are
two to four times that of adults due to relatively
larger brain mass as compared to the total body mass
and cerebral metabolism.
Diagnostic features of hyperinsulinemia are;
serum glucose level <60 mg/dl, non-ketotic
hypoglycaemia associated with elevated insulin
levels (>10 mU/ml) and sustained glucose
requirement in excess of 10 mg/kg/min.
EU glycaemia and prevention of brain injury from
neuroglycopenia are the main goals of medical
management. Timely nasogastric feeds, dextrose
infusion (10–15%) and drugs like diazoxide,
somatostatin or glucagon play an important role in
medical management. Thiopentone has also been
used in medical management.5 Phenytoin also inhibits
release of insulin from beta-cells and hence may be
helpful in the prevention of hypoglycaemia.6
Both our children were receiving
somatostatin which inhibits endocrine function of the
normal pancreas. Somatostatin can inhibit growth
hormone which causes poor growth, diarrhoea,
vomiting and hepatic impairment leading to
electrolyte disturbances.
The goals for our anaesthetic management
was to prevent intraoperative hypoglycaemia, avoid
thiopentone for patients receiving diazoxide therapy
and to maintain fluid shifts of major surgery.
In hyperinsulinemia, the requirement of
glucose increases to 10 mg/kg/min. When boluses of
high concentration dextrose containing fluids are
used, the blood glucose level could exceed renal
threshold for glucose causing glycosuria and osmotic
diuresis. Hence, it is preferable to use the dextrose
containing fluid as maintenance and Ringer lactate as
replacement solution. We use half strength dextrose
saline (50ml/hr) as a maintenance fluid in our first
case while using 10% dextrose (20 ml/hr) as
maintenance fluid and Ringer’s lactate (10ml/kg/hr)
as replacement solution in second case.
Combination of epidural and general
anaesthesia in infants also reduces the glucose
requirement during surgery.7With the exception of
desflurane, most of the volatile anaesthetics depresses
the release of insulin and promote glucose
intolerance.8
After the pancreatic mass excision, rebound
hyperglycaemia can occur but it is transient and is
resolves spontaneously in most cases. Persistent
rebound hyperglycaemia was not seen in our cases.
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In summary, the successful anaesthetic management
depends on the maintenance of normoglycemia,
maintaining fluid management and stabilization of
the haemodynamic throughout surgery.
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